Journal of Substance Abuse Treatment
Volume 42, Issue 2 , Pages 116-124 , March 2012

Drug treatment program ownership, Medicaid acceptance, and service provision

  • Duane C. McBride, Ph.D.

      Affiliations

    • Institute for Prevention of Addictions, Andrews University, Berrien Springs, MI 49104-0211, USA
    • Corresponding Author InformationCorresponding author. Institute for Prevention of Addictions, Andrews University, Berrien Springs, MI 49104-0211, USA. Tel.: +1 269 471 3558; fax: +1 269 471 6611.
    • ,
  • Jamie F. Chriqui, Ph.D.

      Affiliations

    • Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, IL 60608, USA
    • ,
  • Yvonne M. Terry-McElrath, M.S.A.

      Affiliations

    • Institute for Social Research, University of Michigan, Ann Arbor, MI 48106-1248, USA
    • ,
  • Mesfin S. Mulatu, Ph.D.

      Affiliations

    • The MayaTech Corporation, Silver Spring, MD, 20910-3921, USA

Received 7 June 2011 ,Revised 27 September 2011 ,Accepted 18 October 2011.

References 

  1. Aaronson WE, Zinn JS, Rosko MD. Do for-profit and not-for-profit nursing homes behave differently?. Gerontologist. 1994;34:775–786
  2. Aday LA, Begley CE, Lairson DR, Balkrishnan R. Evaluating the healthcare system: Effectiveness, efficiency, and equity. 3rd ed. Chicago, IL: Health Administration Press; 2004;
  3. Alexander JA, Wells R, Jiang L, Pollack H. Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programs. Health Services Management Research. 2008;21:168–177
  4. Amierkhanyan AA, Kimn HJ, Lambright KT. Does the public sector outperform the nonprofit and for-profit sectors? Evidence from a national panel study on nursing home quality and access. Journal of Policy Analysis Management. 2008;27:326–353
  5. Asche SE, Harrison PA. The relationship between problem severity and ancillary treatment services: Is substance abuse treatment responsive to client need?. The Journal of Behavioral Health Services and Research. 2002;29:345–356
  6. Berkman N, Roussel AE, Wechsberg WM, Diesenhaus H. Access to special and ancillary services in methadone treatment programs. Abstracts of the Academy for Health Services Research and Policy Meeting 18:50. Available at http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102273243.html2001;(accessed March 18, 2011)
  7. Buck JA. The looming expansion and transformation of public substance treatment under The Affordable Care Act. Health Affairs. 2011;30:1402–1410
  8. Chriqui JF, Terry-McElrath YM, McBride DC, Edison SS, Vander Waal CJ. Does state certification or licensure influence outpatient substance abuse treatment programs?. Journal of Behavioral Health Services and Research. 2007;34:309–328
  9. Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatric Services. 2009;60:35–42
  10. Comiskey CM, Stapleton R. Longitudinal outcomes for treated opiate use and the use of ancillary medical and social services. Substance Use and Misuse. 2010;45:628–641
  11. Cook P, Dogoloff ML, Harteker L, Nelson AE, Paul MM, Shuman DJ, et al. Comprehensive case management for substance abuse treatment. Treatment Improvement Protocol (TIP) Series 27. Rockville, MD: Substance Abuse and Mental health Services Administration (SMA-98-3222); 1998;
  12. Crampton P, Davis P, Lay-Yee R, Raymont A, Forrest C, Starfield B. Comparison of private for-profit with private community-governed not-for-profit primary care services in New Zealand. Journal of Health Services Research & Policy. 2004;9:17–22
  13. Deck, D. D., & Gabriel, R. M. (2011). Impact of eliminating Medicaid treatment benefits. In B. H. McFarland, D. McCarty, & A. E. Kovas (Eds.), Medicaid and treatment for people with substance abuse problems (pp. 223-230). Hauppauge, NY: Nova Science Publishers.
  14. Deck DD, Wiitala WL, Laws KE. Medicaid coverage and access to publicly funded opiate treatment. Journal of Behavioral Health Services and Research. 2006;33:324–334
  15. Ducharme LJ, Abraham AJ. State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention, and Policy. 2008;3:1–10
  16. Ducharme LJ, Mello HL, Roman PM, Knudsen HK, Johnson JA. Service delivery in substance abuse treatment: Reexamining “comprehensive” care. Journal of Behavioral Health Services and Research. 2007;34:121–136
  17. Heinrich CJ, Hill CJ. Role of state policies in the adoption of naltrexone for substance abuse treatment. Health Services Research. 2008;43:951–970
  18. Holahan J, Headen I. Medicaid coverage and spending in health reform: National and state-by-state results for adults at or below 133% FPL, executive summary (Report No. 8076-ES). Washington, DC: Kaiser Family Foundation, Kaiser Commission on Medicaid and the Uninsured; 2010;Available at http://www.kff.org/healthreform/upload/Medicaid-Coverage-and-Spending-in-Health-Reform-National-and-State-By-State-Results-for-Adults-ator-Below-133-FPL-Executive-Summary.pdf(accessed August 16, 2010)
  19. Institute of Medicine . Improving the quality of health care for mental and substance-use conditions. Institute of Medicine, Committee on Crossing the Quality Chasm: Adaption to Mental Health and Addictive Disorders. Washington, D.C.: National Academies Press; 2006;
  20. Jaffe S. Health policy brief: Key issues in health reform. Health Affairs, August 20. Available at http://www.rwjf.org/files/research/82409healthaffairs7.pdf2009;(accessed March 18, 2011)
  21. Knopf A. Future of private residential treatment called into question by CMS official. Alcoholism and Drug Abuse Weekly, August 15. Available at http://www.alcoholismdrugabuseweekly.com/article-print-page/future-private-residential-treatment-called-into-question.aspx2011;(accessed September 16, 2011)
  22. Krupski A, Campbell K, Joesch JM, Lucenko BA, Roy-Byrne P. Impact of access to recovery services on alcohol/drug treatment outcomes. Journal of Substance Abuse Treatment. 2009;37:345–442
  23. Lewandowski CA, Hill TJ. The impact of emotional and material social support on women's drug treatment completion. Health and Social Work. 2009;34:213–221
  24. Mark TL, Levit KR, Vandivort-Warren R, Coffey RM, Buck JA. Trends in spending for substance abuse treatment, 1986–2003. Health Affairs. 2007;26:1118–1128
  25. Meisenheimer CG. Improving quality: A guide to effective programs. Gaithersburg, MD: Aspen Publishers; 1997;
  26. Morey RC, Dittman DA. Cost pass-through reimbursement to hospitals and their impacts on operating efficiencies. Annals of Operations Research. 1996;67:117–139
  27. Morgenstern J, Blanchard KA, Kahler C, Barbosa KM, McCrady BS, McVeigh KH. Testing mechanisms of action for intensive case management. Addiction. 2008;103:469–477
  28. Morgenstern J, Hogue A, Dauber S, Dasaro C, McKay JR. A practical clinical trial of coordinated care management to treat substance use disorders among public assistance beneficiaries. Journal of Consulting and Clinical Psychology. 2009;77:257–269
  29. Nahra TA, Alexander J, Pollack H. Influence of ownership on access in outpatient substance abuse treatment. Journal of Substance Abuse Treatment. 2009;36:355–365
  30. National Institute on Drug Abuse . Principles of drug addiction treatment: A research-based guide (2nd ed). Bethesda, MD: National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services; 2009;(NIH Publication No.09-4180)
  31. Olmstead T, Sindelar JL. To what extent are key services offered in treatment programs for special populations. Journal of Substance Abuse Treatment. 2004;27:9–15
  32. Oser C, Knudsen H, Staton-Tindall M, Leukefeld C. The adoption of wraparound services among substance abuse treatment organizations serving criminal offenders: The role of a women-specific program. Drug and Alcohol Dependence. 2009;103S:S82–S90
  33. Powell WW, Steinberg R. The non-profit sector. New Haven, CT: Yale University Press; 2006;
  34. Roseanau PV, Linder SH. Two decades of research comparing for-profit and nonprofit health provider performance in the United States. Social Science Quarterly. 2003;84:219–241
  35. Rush B, Corea L, Martin G. Monitoring alcohol and other drug treatment: What would an optimal system look like?. Contemporary Drug Problems. 2009;36:545–574
  36. Schlesinger M, Gray B, Bradley E. Charity and community: The role of nonprofit ownership in a managed health care system. Journal of Health Politics, Policy and Law. 1996;21:697–750
  37. Siegal HA, Fisher JA, Rapp RC, Kelliher CW, Wagner JH, O'Brien WF, et al. Enhancing substance abuse treatment with case management: its impact on employment. Journal of Substance Abuse Treatment. 1996;13:93–98
  38. Sloan FA, Picone GA, Taylor DH, Chou SY. Hospital ownership and cost and quality care: Is there a dime's worth of difference?. Journal of Health Economics. 2001;20:1–21
  39. Substance Abuse and Mental Health Services Administration . The N-SSATS report: Services provided by substance abuse treatment facilities in the United States. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2009;
  40. Substance Abuse and Mental Health Services Administration. Office of Applied Studies . Treatment Episode Data Set–Admissions (TEDS-A)—Concatenated, 1992 to present [Computer file]. ICPSR25221-v3. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2010-05-04; 2010;doi:10.3886/ICPSR25221
  41. Substance Abuse and Mental Health Services Administration . NREPP: National registry of evidence-based programs and practices. Rockville, MD: Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services; 2011;Available at http://www.nrepp.samhsa.gov/ViewAll.aspx(accessed February 5, 2011)
  42. Taxman FS, Byrne JM, Thanner MH. Evaluating the implementation and impact of a seamless system of care for substance abusing offenders: The HIDTA model (National Criminal Justice Reference Service: Document number 197046). Washington, DC: National Criminal Justice Reference Service; 2002;
  43. Terry-McElrath YM, Chriqui JF, McBride DC. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs. Health Services Research. 2011;46:632–653
  44. Wheeler JRC, Nahra TA. Private and public ownership in outpatient substance abuse treatment: Do we have a two-tiered system?. Administration and Policy in Mental Health. 2000;27:197–209
  45. Wheeler JRC, Fadel H, D'Aunno TA. Ownership and performance of outpatient substance abuse treatment. American Journal of Public Health. 1992;82:711–719

PII: S0740-5472(11)00210-8

doi: 10.1016/j.jsat.2011.10.007

Journal of Substance Abuse Treatment
Volume 42, Issue 2 , Pages 116-124 , March 2012

Article Tools